Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality worldwide, primarily resulting from an abrupt coronary artery occlusion that deprives myocardial tissue of oxygen.
Slower heart rate recovery before PCI independently predicts periprocedural myocardial infarction and may improve cardiac risk assessment.
Use of beta-blockers has been a cornerstone in the treatment era following acute myocardial infarction (MI), especially in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback